Effect on cognitive function.
- Conditions
- Healthy subjects
- Registration Number
- JPRN-UMIN000031366
- Lead Sponsor
- CPCC Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 14
Not provided
1) Subjects who constantly use medicines, supplements having a possibility of affecting test results. 2) Subjects who have previous and/or current medical history of serious disease such as cerebral infarction, cerebrovascular disease, psychosis, dementia and so on. 3) Subjects who excessive alcohol intake and excess smoker. 4) Subjects who have extremely irregular dining habits, and subjects who have midnight work or irregular shift work. 5) Subjects who have previous medical history of drug and/or food (especially gelatin) allergy. 6) Subjects who are participating the other clinical tests. Subjects who participated within 4-weeks prior to the current study and/or who plan to participate the other clinical tests. 7) Subjects who donated over 200mL blood and/or blood components within the last one month to the current study. 8) Males who donated over 400mL blood and/or blood components within the last three month to the current study. 9) Females who donated over 400mL blood and/or blood components within the last four month to the current study. 10) Males who will be collected over 1200mL blood and/or blood components, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 11) Females who will be collected over 800mL blood and/or blood components when, the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 12) Subjects who are positive for infectious. 13) Others who have been determined ineligible by principal investigator or sub-investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MMSE-J score
- Secondary Outcome Measures
Name Time Method MCI screening test, Brain blood flow measurement using NIRS, Self-rating Depression Scale developed by Zung, Social Readjustment Rating Scale by Holmes, Uchida-Kraepelin test, BAP test and quantification of cortisol in salivary